OPTINOSE INC (OPTN) Stock Price, Quote, News and Overview
NASDAQ:OPTN - Nasdaq - US68404V2097 - Common Stock - Currency: USD
OPTN Quote, Performance and Key Statistics
NASDAQ:OPTN (4/17/2025, 8:00:02 PM)
9.17
+0.01 (+0.11%)
The current stock price of OPTN is 9.17 USD. In the past month the price increased by 0.22%. In the past year, price decreased by -31.63%.
OPTN Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 64.61 | 796.27B | ||
| JNJ | JOHNSON & JOHNSON | 15.67 | 379.48B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 16.83 | 257.82B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 13.96 | 218.96B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 16.29 | 209.55B | ||
| MRK | MERCK & CO. INC. | 10.21 | 196.28B | ||
| PFE | PFIZER INC | 7.12 | 125.57B | ||
| SNY | SANOFI-ADR | 11.41 | 124.61B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 43.18 | 100.17B | ||
| GSK | GSK PLC-SPON ADR | 8.3 | 72.81B | ||
| ZTS | ZOETIS INC | 25.11 | 66.32B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 31.98 | 46.30B |
Related stock screener links
About OPTN
Company Profile
OptiNose, Inc. operates as a pharmaceutical company. The company is headquartered in Yardley, Pennsylvania and currently employs 132 full-time employees. The company went IPO on 2017-10-13. The firm's product, XHANCE (fluticasone propionate) nasal spray, 93 microgram (mcg), is a therapeutic utilizing its Exhalation Delivery System (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps and chronic rhinosinusitis without nasal polyps (also known as chronic sinusitis). XHANCE combines the EDS with a liquid formulation of fluticasone propionate, a well-characterized, second-generation corticosteroid. XHANCE is designed to deliver medication into the high and deep regions of the nasal passages where both nasal polyps and inflamed and swollen membranes can obstruct normal sinus ventilation and drainage. The firm has developed both a liquid delivery EDS and a powder delivery EDS utilizing natural functional behaviors of the upper nasal airways intended to offer better drug deposition.
Company Info
OPTINOSE INC
777 Township Line Road, Suite 300
Yardley PENNSYLVANIA 19067 US
CEO: Peter K. Miller
Employees: 132
Company Website: https://www.optinose.com/
Investor Relations: http://ir.optinose.com/
Phone: 12673643500
OPTINOSE INC / OPTN FAQ
What is the stock price of OPTINOSE INC today?
The current stock price of OPTN is 9.17 USD. The price increased by 0.11% in the last trading session.
What is the ticker symbol for OPTINOSE INC stock?
The exchange symbol of OPTINOSE INC is OPTN and it is listed on the Nasdaq exchange.
On which exchange is OPTN stock listed?
OPTN stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for OPTINOSE INC stock?
10 analysts have analysed OPTN and the average price target is 18.36 USD. This implies a price increase of 100.22% is expected in the next year compared to the current price of 9.17. Check the OPTINOSE INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is OPTINOSE INC worth?
OPTINOSE INC (OPTN) has a market capitalization of 92.80M USD. This makes OPTN a Micro Cap stock.
How many employees does OPTINOSE INC have?
OPTINOSE INC (OPTN) currently has 132 employees.
What are the support and resistance levels for OPTINOSE INC (OPTN) stock?
OPTINOSE INC (OPTN) has a support level at 9.13 and a resistance level at 9.18. Check the full technical report for a detailed analysis of OPTN support and resistance levels.
Is OPTINOSE INC (OPTN) expected to grow?
The Revenue of OPTINOSE INC (OPTN) is expected to grow by 27.03% in the next year. Check the estimates tab for more information on the OPTN EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy OPTINOSE INC (OPTN) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of OPTN, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of OPTN, evaluating the profitability, health, valuation and growth aspects
- OPTINOSE INC (OPTN) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- OPTINOSE INC (OPTN) Sales and EPS estimates to see what analysts future expectations are.
- OPTINOSE INC (OPTN) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- OPTINOSE INC (OPTN) Insider and Institutional Ownership to learn about the owners and their transactions.
- OPTINOSE INC (OPTN) Stock Chart to make your own analysis
- OPTINOSE INC (OPTN) Latest news and press-releases to stay up to date.
Does OPTINOSE INC (OPTN) stock pay dividends?
OPTN does not pay a dividend.
When does OPTINOSE INC (OPTN) report earnings?
OPTINOSE INC (OPTN) will report earnings on 2025-05-12, before the market open.
What is the Price/Earnings (PE) ratio of OPTINOSE INC (OPTN)?
OPTINOSE INC (OPTN) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.58).
What is the Short Interest ratio of OPTINOSE INC (OPTN) stock?
The outstanding short interest for OPTINOSE INC (OPTN) is 2.6% of its float. Check the ownership tab for more information on the OPTN short interest.
OPTN Technical Analysis
ChartMill assigns a technical rating of 9 / 10 to OPTN. When comparing the yearly performance of all stocks, OPTN is one of the better performing stocks in the market, outperforming 81.98% of all stocks.
OPTN Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to OPTN. OPTN has a bad profitability rating. Also its financial health evaluation is rather negative.
OPTN Financial Highlights
Over the last trailing twelve months OPTN reported a non-GAAP Earnings per Share(EPS) of -2.58. The EPS decreased by -706.25% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -27.65% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
OPTN Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 78% to OPTN. The Buy consensus is the average rating of analysts ratings from 10 analysts.
For the next year, analysts expect an EPS growth of 0.24% and a revenue growth 27.03% for OPTN